Bart Rikhof
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
- Rheumatology top 10%
- Soft tissue tumor case studies
Papers in
-
- Metabolism, Diabetes, and Cancer 2
-
- Sarcoma Diagnosis and Treatment 3
- Renal cell carcinoma treatment 1
- Co-authors
- Winette T.A. van der Graaf (9 shared papers)Albert J.H. Suurmeijer (5 shared papers)Steven de Jong (4 shared papers)Coby Meijer (3 shared papers)J. van Doorn (2 shared papers)Henk Bilo (1 shared paper)A.H. Honkoop (1 shared paper)Paul G. Corn (1 shared paper)
- Journals
- European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Acta Oncologica (1 paper)Journal of Clinical Oncology (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Bart Rikhof
14 papers receiving 479 citations
Peers
Comparison fields: 5 of 52
- Gastroenterology 71
- Rheumatology 106
- Pulmonary and Respiratory Medicine 180
- Endocrinology, Diabetes and Metabolism 87
- Cancer Research 63
Countries citing papers authored by Bart Rikhof
This map shows the geographic impact of Bart Rikhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Rikhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Rikhof more than expected).
Fields of papers citing papers by Bart Rikhof
This network shows the impact of papers produced by Bart Rikhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Rikhof. The network helps show where Bart Rikhof may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Rikhof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 162 | |
| 2 | 2008 | 114 | |
| 3 | 2007 | 45 | |
| 4 | The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study. | 2012 | 39 |
| 5 | 2003 | 35 | |
| 6 | 2009 | 19 | |
| 7 | 2005 | 19 | |
| 8 | 2008 | 16 | |
| 9 | 2012 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2013 | 11 | |
| 12 | 2024 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2008 | 1 |
About Bart Rikhof
Bart Rikhof is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Rheumatology, Gastroenterology and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 491 indexed citations. Recurring topics across this work include Soft tissue tumor case studies (4 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Renal cell carcinoma treatment (1 paper) and Gastrointestinal disorders and treatments (1 paper). The work is most often cited by research in Gastroenterology (71 citations), Rheumatology (106 citations), Pulmonary and Respiratory Medicine (180 citations), Endocrinology, Diabetes and Metabolism (87 citations) and Cancer Research (63 citations). Bart Rikhof has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Winette T.A. van der Graaf, Albert J.H. Suurmeijer, Steven de Jong, Coby Meijer, J. van Doorn, Henk Bilo, A.H. Honkoop, Paul G. Corn, Wafik S. El‐Deiry and Jourik A. Gietema. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Acta Oncologica, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.